FDA Advisors Will Scrutinize CT Colonography Evidence
This article was originally published in The Gray Sheet
Executive Summary
Two FDA advisory panels will come together Sept. 9 to consider the latest evidence supporting computed tomography colonography as a general screening tool for colorectal cancer. The technique has been touted as a less invasive option to traditional colonoscopy, but its use has been strongly questioned due to risks from radiation exposure and false positives.
You may also be interested in...
Federal Task Force To Consider CT Colonography As Screening Option
The U.S. Preventive Services Task Force released a draft research plan for public comment that considers CT colonography as a screening test to reduce risks and death from colorectal cancer.
FDA Gastroenterology, Radiology Advisors Finally Agree: CT Colonography Benefits Outweigh Risks
New research findings presented at a joint meeting of FDA’s gastroenterology and radiological devices panels persuaded experts that CT colonography is safe and works well for screening adults over 50 for colorectal cancer.
FDA Gastroenterology, Radiology Advisors Finally Agree: CT Colonography Benefits Outweigh Risks
New research findings presented at a joint meeting of FDA’s gastroenterology and radiological devices panels persuaded experts that CT colonography is safe and works well for screening adults over 50 for colorectal cancer.